Finance

Lists
TTI:CVE
Thiogenesis Therapeutics Corp
0,51 CA$
+2,00%
(+0,0100) 1D
19 հոկ, 16:00:00 GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for TTI...
Open
0,53 CA$
High
0,53 CA$
Low
0,51 CA$
Mkt. cap
35,69 մլն
Avg. vol.
46,63 հզր
Volume
4,50 հզր
52-wk high
0,81 CA$
52-wk low
0,44 CA$
EPS
-0,12 CA$
Beta
0,44
Shares outstanding
69,98 մլն
Open
0,53 CA$
High
0,53 CA$
Low
0,51 CA$
Mkt. cap
35,69 մլն
Avg. vol.
46,63 հզր
Volume
4,50 հզր
52-wk high
0,81 CA$
52-wk low
0,44 CA$
EPS
-0,12 CA$
Beta
0,44
Shares outstanding
69,98 մլն
News stories
From web sources and news partners
About Thiogenesis Therapeutics Corp
CEO-
Employees-
Founded2018
HeadquartersՏորոնտո, Օնտարիո, Կանադա
Sector-
Websitethiogenesis.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1,92 մլն
1,27 մլն
579,55 հզր
1,24 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
471,84 հզր
464,40 հզր
338,28 հզր
242,34 հզր
Operating expense
2,39 մլն
1,73 մլն
917,82 հզր
1,48 մլն
Total operating expenses
2,39 մլն
1,73 մլն
917,82 հզր
1,48 մլն
Operating income
-2,39 մլն
-1,73 մլն
-917,82 հզր
-1,48 մլն
Other non operating income
-
-
-
-
EBT including unusual items
-2,38 մլն
-1,73 մլն
-911,82 հզր
-1,49 մլն
EBT excluding unusual items
-2,38 մլն
-1,73 մլն
-911,82 հզր
-1,49 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2,38 մլն
-1,73 մլն
-911,82 հզր
-1,49 մլն
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
6,45 հզր
4,42 հզր
51,00
2,18 հզր
Interest expense
-
-
-
-
Net interest expenses
6,45 հզր
4,42 հզր
51,00
2,18 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps